BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)
EUR 0.05
(0.0%)
EUR 0.05
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.14 Million EUR | -15.53% |
| 2022 | -2.72 Million EUR | -16.53% |
| 2021 | -2.33 Million EUR | 3.76% |
| 2020 | -2.43 Million EUR | -85.5% |
| 2019 | -1.31 Million EUR | -285.49% |
| 2018 | 632.47 Thousand EUR | 157.21% |
| 2017 | -4.22 Million EUR | -151.02% |
| 2016 | -599.87 Thousand EUR | -26.48% |
| 2015 | -387 Thousand EUR | -281.7% |
| 2014 | -101.91 Thousand EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -742.00 EUR | 55.94% |
| 2024 Q2 | -742.00 EUR | 99.9% |
| 2023 FY | - EUR | -15.52% |
| 2023 Q2 | -1.46 Million EUR | -200036.52% |
| 2023 Q4 | -1.68 Million EUR | -200176.87% |
| 2023 Q1 | -732.50 EUR | 99.95% |
| 2023 Q3 | -840.84 EUR | 99.94% |
| 2022 Q2 | -1.36 Million EUR | -199880.7% |
| 2022 Q4 | -1.35 Million EUR | -199890.58% |
| 2022 Q3 | -679.47 EUR | 99.95% |
| 2022 FY | - EUR | -16.53% |
| 2022 Q1 | -683.83 EUR | 99.94% |
| 2021 Q3 | -593.29 EUR | 99.95% |
| 2021 Q2 | -1.15 Million EUR | -199981.84% |
| 2021 Q4 | -1.18 Million EUR | -199764.15% |
| 2021 Q1 | -576.74 EUR | 99.95% |
| 2021 FY | - EUR | 3.76% |
| 2020 Q1 | -637.89 EUR | 99.9% |
| 2020 Q3 | -577.65 EUR | 99.95% |
| 2020 Q4 | -1.15 Million EUR | -199875.07% |
| 2020 FY | - EUR | -85.5% |
| 2020 Q2 | -1.27 Million EUR | -199923.52% |
| 2019 Q3 | -306.97 EUR | 99.96% |
| 2019 FY | - EUR | -285.49% |
| 2019 Q4 | -613.91 Thousand EUR | -199888.92% |
| 2019 Q1 | -348.50 EUR | -24.53% |
| 2019 Q2 | -696.61 Thousand EUR | -199789.81% |
| 2018 Q3 | -279.85 EUR | 45.77% |
| 2018 FY | - EUR | 157.21% |
| 2018 Q4 | -279.85 EUR | 0.0% |
| 2018 Q1 | -516.01 EUR | -34.87% |
| 2018 Q2 | -516.01 EUR | 0.0% |
| 2017 FY | - EUR | -151.02% |
| 2017 Q1 | -254.84 EUR | 0.0% |
| 2017 Q2 | -254.84 EUR | 0.0% |
| 2017 Q3 | -382.59 EUR | -50.13% |
| 2017 Q4 | -382.59 EUR | 0.0% |
| 2016 FY | - EUR | -26.48% |
| 2015 FY | - EUR | -281.7% |
| 2014 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Modulight Oyj | -10.44 Million EUR | 69.845% |
| Nexstim Plc | -935.5 Thousand EUR | -236.681% |
| Revenio Group Oyj | 30.09 Million EUR | 110.468% |